Literature DB >> 2701653

Asparagine-linked oligosaccharides associated with metastatic cancer.

J W Dennis1, S Laferté, S Yagel, M L Breitman.   

Abstract

Malignant transformation and tumor progression are often accompanied by structural changes in the carbohydrate components of glycoproteins and glycolipids. Studies with tumor cell glycosylation mutants and specific inhibitors of glycosylation indicate that expression of sialylated and beta (1-6) branched asparagine (Asn)-linked oligosaccharides are required for tumor cell invasion and metastasis. The initiation of the beta (1-6) antenna appears to be oncodevelopmentally regulated and may be associated with the aberrant expression of blood group and embryonic carbohydrate sequences in Asn-linked oligosaccharides of tumors. Although the function of these oligosaccharides in the metastatic process remains unclear, there is some evidence that expression of these structures on certain cell-surface glycoproteins may reduce tumor cell adhesion to extracellular matrix. These observations suggest that low-toxicity drugs that inhibit the biosynthesis of these structures may be useful in the treatment of metastatic cancers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2701653

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  11 in total

1.  Antimetabolite-induced increases in the invasive capacity of murine leukaemia L1210 cells.

Authors:  T W De Graaf; G J Peters; W van Dijk
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

2.  Characterization of a family of structurally related glycoproteins expressing beta 1-6-branched asparagine-linked oligosaccharides in human colon carcinoma cells.

Authors:  S Laferté; L C Loh
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

3.  CMP-N-acetylneuraminic acid hydroxylase activity determines the wheat germ agglutinin-binding phenotype in two mutants of the lymphoma cell line MDAY-D2.

Authors:  L Shaw; S Yousefi; J W Dennis; R Schauer
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

4.  Swainsonine promotes apoptosis in human oesophageal squamous cell carcinoma cells in vitro and in vivo through activation of mitochondrial pathway.

Authors:  Zhaocal Li; Yong Huang; Feng Dong; Wei Li; Li Ding; Gaoshui Yu; Dan Xu; Yuanyuan Yang; Xingang Xu; Dewen Tong
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

Review 5.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec

6.  siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer.

Authors:  Alix Bee; Daniel Brewer; Carol Beesley; Andrew Dodson; Shiva Forootan; Timothy Dickinson; Patricia Gerard; Brian Lane; Sheng Yao; Colin S Cooper; Mustafa B A Djamgoz; Christine M Gosden; Youqiang Ke; Christopher S Foster
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

7.  Swainsonine activates mitochondria-mediated apoptotic pathway in human lung cancer A549 cells and retards the growth of lung cancer xenografts.

Authors:  Zhaocai Li; Xingang Xu; Yong Huang; Li Ding; Zhisheng Wang; Gaoshui Yu; Dan Xu; Wei Li; Dewen Tong
Journal:  Int J Biol Sci       Date:  2012-02-24       Impact factor: 6.580

8.  Migrating endothelial cells are distinctly hyperglycosylated and express specific migration-associated cell surface glycoproteins.

Authors:  H G Augustin-Voss; B U Pauli
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

9.  Tumor cell surface beta 1-4-linked galactose binds to lectin(s) on microvascular endothelial cells and contributes to organ colonization.

Authors:  I Cornil; R S Kerbel; J W Dennis
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

10.  Different expression levels of glycans on leukemic cells-a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid.

Authors:  Zahra El-Schich; Mohammad Abdullah; Sudhirkumar Shinde; Nishtman Dizeyi; Anders Rosén; Börje Sellergren; Anette Gjörloff Wingren
Journal:  Tumour Biol       Date:  2016-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.